Some studies revealed NF-κB signaling can be activated by upstream kinases involved in tumor progression such as protein kinase B (PKB/AKT), mitogen-activated protein kinase (MAPKs), or protein kinase C delta (PKCδ) in CRC [14,15,16]. This evidence concerns the gene AKT1 and colorectal carcinoma.